These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

708 related items for PubMed ID: 22202499

  • 1. Lung transplantation across donor-specific anti-human leukocyte antigen antibodies: utility of bortezomib therapy in early graft dysfunction.
    Stuckey LJ, Kamoun M, Chan KM.
    Ann Pharmacother; 2012 Jan; 46(1):e2. PubMed ID: 22202499
    [Abstract] [Full Text] [Related]

  • 2. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL, Terasaki PI, Feroz A, Everly MJ, Vanikar AV, Shankar V, Trivedi VB, Kaneku H, Idica AK, Modi PR, Khemchandani SI, Dave SD.
    Transplantation; 2009 May 27; 87(10):1555-61. PubMed ID: 19461494
    [Abstract] [Full Text] [Related]

  • 3. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.
    Walsh RC, Everly JJ, Brailey P, Rike AH, Arend LJ, Mogilishetty G, Govil A, Roy-Chaudhury P, Alloway RR, Woodle ES.
    Transplantation; 2010 Feb 15; 89(3):277-84. PubMed ID: 20145517
    [Abstract] [Full Text] [Related]

  • 4. Reduction of alloantibodies via proteasome inhibition in cardiac transplantation.
    Patel J, Everly M, Chang D, Kittleson M, Reed E, Kobashigawa J.
    J Heart Lung Transplant; 2011 Dec 15; 30(12):1320-6. PubMed ID: 21968130
    [Abstract] [Full Text] [Related]

  • 5. Proteasome inhibitor treatment of antibody-mediated allograft rejection.
    Woodle ES, Alloway RR, Girnita A.
    Curr Opin Organ Transplant; 2011 Aug 15; 16(4):434-8. PubMed ID: 21753709
    [Abstract] [Full Text] [Related]

  • 6. Bortezomib alone fails to decrease donor specific anti-HLA antibodies: 4 case reports.
    Sberro-Soussan R, Zuber J, Suberbielle-Boissel C, Legendre C.
    Clin Transpl; 2009 Aug 15; ():433-8. PubMed ID: 20524311
    [Abstract] [Full Text] [Related]

  • 7. Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.
    Everly MJ, Everly JJ, Susskind B, Brailey P, Arend LJ, Alloway RR, Roy-Chaudhury P, Govil A, Mogilishetty G, Rike AH, Cardi M, Wadih G, Tevar A, Woodle ES.
    Transplantation; 2008 Dec 27; 86(12):1754-61. PubMed ID: 19104417
    [Abstract] [Full Text] [Related]

  • 8. Proteasome inhibition by bortezomib: effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation.
    Guthoff M, Schmid-Horch B, Weisel KC, Häring HU, Königsrainer A, Heyne N.
    Transpl Immunol; 2012 Jun 27; 26(4):171-5. PubMed ID: 22326708
    [Abstract] [Full Text] [Related]

  • 9. Case presentations on two patients who received bortezomib for antibody mediated rejection at BIDMC.
    Pavlakis M.
    Clin Transpl; 2009 Jun 27; ():343-5. PubMed ID: 20524296
    [Abstract] [Full Text] [Related]

  • 10. Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients.
    Morrow WR, Frazier EA, Mahle WT, Harville TO, Pye SE, Knecht KR, Howard EL, Smith RN, Saylors RL, Garcia X, Jaquiss RD, Woodle ES.
    Transplantation; 2012 Feb 15; 93(3):319-24. PubMed ID: 22179403
    [Abstract] [Full Text] [Related]

  • 11. The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection.
    Hardinger KL, Murillo D.
    Clin Transpl; 2011 Feb 15; ():401-8. PubMed ID: 22755438
    [Abstract] [Full Text] [Related]

  • 12. Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody.
    Hodges AM, Lyster H, McDermott A, Rice AJ, Smith JD, Rose ML, Banner NR.
    Transplantation; 2012 Mar 27; 93(6):650-6. PubMed ID: 22245878
    [Abstract] [Full Text] [Related]

  • 13. HLA desensitization with bortezomib in a highly sensitized pediatric patient.
    May LJ, Yeh J, Maeda K, Tyan DB, Chen S, Kaufman BD, Bernstein D, Rosenthal DN, Hollander SA.
    Pediatr Transplant; 2014 Dec 27; 18(8):E280-2. PubMed ID: 25174602
    [Abstract] [Full Text] [Related]

  • 14. Use of bortezomib for prevention and treatment of rejection in sensitized patients.
    Hartono C, Lubetzky M, Aull MJ, Saal S, Figueiro J, Kapur S, Dadhania D.
    Clin Transpl; 2009 Dec 27; ():499-503. PubMed ID: 20524323
    [Abstract] [Full Text] [Related]

  • 15. Elimination of post-transplant donor-specific HLA antibodies with bortezomib.
    Idica A, Kaneku H, Everly MJ, Trivedi HL, Feroz A, Vanikar AV, Shankar V, Trivedi VB, Modi PR, Khemchandani SI, Dave SD, Terasaki PI.
    Clin Transpl; 2008 Dec 27; ():229-39. PubMed ID: 19708459
    [Abstract] [Full Text] [Related]

  • 16. Acute rejection in a highly sensitized lung transplant recipient with pre-formed donor-directed anti-HLA class II antibodies: role of bortezomib therapy.
    Stuckey LJ, Kamoun M, Wadhwa A, Samaniego M, Bartos C, Berry J, Mahidhara R, Chang AC, Chan KM.
    Clin Transpl; 2009 Dec 27; ():471-4. PubMed ID: 20524317
    [No Abstract] [Full Text] [Related]

  • 17. Proteasome inhibition for antibody-mediated rejection.
    Everly JJ, Walsh RC, Alloway RR, Woodle ES.
    Curr Opin Organ Transplant; 2009 Dec 27; 14(6):662-6. PubMed ID: 19667989
    [Abstract] [Full Text] [Related]

  • 18. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J, Xue W, Qing X, Jing X, Hou J, Tian X, Guo Q, He X, Cai J.
    Clin Transpl; 2014 Dec 27; ():223-30. PubMed ID: 26281149
    [Abstract] [Full Text] [Related]

  • 19. Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation.
    Sureshkumar KK, Hussain SM, Marcus RJ, Ko TY, Khan AS, Tom K, Vivas CA, Parris G, Jasnosz KM, Thai NL.
    Clin Nephrol; 2012 Mar 27; 77(3):246-53. PubMed ID: 22377258
    [Abstract] [Full Text] [Related]

  • 20. Proteasome inhibitor therapy for antibody-mediated rejection.
    Woodle ES, Walsh RC, Alloway RR, Girnita A, Brailey P.
    Pediatr Transplant; 2011 Sep 27; 15(6):548-56. PubMed ID: 21884344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.